Imunon, Inc. Common Stock
Symbol: IMNN (NASDAQ)
5.10
▲ (1.49%) 0.075
Company Description:
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
Key Stats
- Today's Open: $5.02
- Today's High: $5.185
- Today's Low: $4.935
- Today's Volume: 82.31K
- Yesterday Close: $5.02
- Yesterday High: $5.18
- Yesterday Low: $4.82
- Yesterday Volume: 100.36K
- Last Min Volume: 10
- Last Min High: $5.095
- Last Min Low: $5.095
- Last Min VWAP: $5.095
Company Profile
- Name: Imunon, Inc. Common Stock
- Website: https://www.imunon.com
- Listed Date: 1995-07-24
- Location: LAWRENCEVILLE, NJ
- Market Status: Active
- CIK Number: 0000749647
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $12.66M
- Round Lot: 100
- Outstanding Shares: 2.52M
- Asset Type: CS
RECENT FILINGS FOR IMNN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-08-28 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-07-23 | 8-K | View |
| 2025-07-22 | 8-K | View |
| 2025-07-22 | 424B5 | View |
| 2025-07-14 | 8-K | View |
Latest News on IMNN